Before The Move: Watch Vanda Ahead Of Pruritus Data
September 05, 2017 at 17:01 PM EDT
This month, Vanda Pharmaceuticals will report Phase II data in atopic dermatitis with chronic pruritus.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.